Ads
related to: roche stock
Search results
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today |...
The Motley Fool· 5 days agoViking Therapeutics (VKTX 1.92%) stock is soaring. Two years ago, the share price hovered just above...
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
Bloomberg· 1 day agoEuropean drugmakers that are focused on building portfolios of new medicines have gotten a nod from...
This Biotech Stock is a “Strong Buy” According to Raymond James
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks via Yahoo Finance· 7 days agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer...
Immunovant changes up plans for closely watched autoimmune drugs
BioPharma Dive via Yahoo Finance· 23 hours agoThe company is prioritizing development of an earlier so-called FcRn inhibitor, a type of medicine...
Swiss Market Ends Modestly Higher
RTT News· 4 days agoAfter swinging between gains and losses till around mid afternoon, Swiss stocks found some support on Monday to end the day's session modestly higher..
Exploring Swiss Dividend Stocks In May 2024
Simply Wall St. via Yahoo Finance· 3 days agoIn recent trading, the Swiss market demonstrated resilience, with the benchmark SMI index closing modestly higher after a day of fluctuating gains and...
Stocks Hit A Wall Despite Booming Nvidia: Weekly Review
Investor's Business Daily· 7 days agoThe Nasdaq and S&P 500 hit record highs, but fell back.
Swiss Market Ends Weak Again
RTT News· 2 days agoSwiss stocks turned in a weak performance on Tuesday as concerns about the outlook for Federal Reserve's interest rates weighed on sentiment. Data on U.S. personal income and spending, which ...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 7 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
